Latest Articles

Publication Date
All News Scientific
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism - Nature

Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism Nature

Published: March 26, 2026, 6:57 a.m.
Read Full Article
TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis - geneonline.com

TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis geneonline.com

Published: March 5, 2026, 9:01 a.m.
Read Full Article
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times

KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times

Published: March 3, 2026, 10:06 a.m.
Read Full Article
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours - The Manila Times

Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours The Manila Times

Published: Feb. 19, 2026, 12:12 p.m.
Read Full Article
New 3D model reveals crucial interactions during early embryo development - MSN

New 3D model reveals crucial interactions during early embryo development MSN

Published: Jan. 14, 2026, 7:35 a.m.
Read Full Article
New research reveals developments in non-invasive early testing for endometriosis - Perth is OK!

New research reveals developments in non-invasive early testing for endometriosis Perth is OK!

Published: Jan. 12, 2026, 6:50 a.m.
Read Full Article
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - Sahm

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 9, 2026, 6:18 a.m.
Read Full Article
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 8, 2026, 12:53 p.m.
Read Full Article
Endometrial Protein Sparks Pre-Eclampsia and Development Issues - Bioengineer.org

Endometrial Protein Sparks Pre-Eclampsia and Development Issues Bioengineer.org

Published: Dec. 10, 2025, 11:22 a.m.
Read Full Article
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - The Manila Times

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development The Manila Times

Published: Dec. 4, 2025, 12:30 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!